Skip to content

Effect of Practical Demonstration to Use Nasal Spray and Apply Intranasal Ointment on Epistaxis

Effect of Practical Demonstration to Use Nasal Spray and Apply Intranasal Ointment on Outcome, in Cases of Recurrent Pediatric Epistaxis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04217941
Enrollment
300
Registered
2020-01-06
Start date
2018-06-01
Completion date
2018-12-01
Last updated
2020-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epistaxis

Keywords

Epistaxis, Randomized control trial, Health education

Brief summary

To compare the result of verbally educating the parents about method of intranasal antiseptic cream application versus practically educating and demonstrating how to apply cream intra nasally.

Detailed description

The primary outcome variables was control of epistaxis through history and clinical examination on follow up visits

Interventions

PROCEDUREHealth education with practical demonstration of nasal ointment

Health education with practical demonstration of medicine was compared to health education without practical demonstration

DRUGHealth Education and practical demonstration of Nasal spray and intranasal ointment

We compared the effect of Health education and practical demonstration for using nasal spray and apply intranasal ointment compared to health education without practical demonstration

Sponsors

Combined Military Hospital, Pakistan
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Masking description

Single blinded

Eligibility

Sex/Gender
ALL
Age
1 Years to 12 Years
Healthy volunteers
No

Inclusion criteria

* The children of age less than 12 years presenting with anterior recurrent epistaxis

Exclusion criteria

* o Children with bleeding disorders. * Children with liver and renal failure/dysfunction. * Children using anti-coagulants. * Those children who have gross deviated nasal septum or nasal polys etc. * Cases who had history of nasal injuries secondary to trauma.

Design outcomes

Primary

MeasureTime frameDescription
number of epistaxis episodes0ne monthSuccess rate was measured on number of epistaxis episodes after treatment. The primary outcome variables was control of epistaxis through history and clinical examination on follow up visit

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026